Estramon (Estradiol transdermal)
- Drug Name: Estramon
- Generic Name: Estradiol transdermal System
- Dosage Forms and Strengths: Transdermal system available in patches: 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day
- Manufactured by: Novartis Pharmaceuticals Corporation
- Estramon is available in patches containing estrogen (estradiol), and is prescribed for various reasons after menopause. It helps ease moderate to severe hot flashes that occur when estrogen levels drop, causing uncomfortable sensations of warmth and sweating in the face, neck, and chest. It’s also used to manage changes in and around the vagina during menopause.
- For women experiencing a shortage of naturally produced estrogen before menopause due to certain conditions, Estramon can be beneficial. Additionally, it’s used to reduce the risk of osteoporosis, a condition where bones become weak and fragile due to menopause.
- Regular discussions with your healthcare provider about the necessity and continuation of Estramon treatment are important to ensure it’s the right choice for you. If Estramon is solely used for vaginal changes, discussing alternative topical treatments with your healthcare provider is recommended.
Recommended Dosage:
- Initiate treatment with Estramon 0.0375 mg/day, applied to the skin twice a week, to alleviate moderate to severe symptoms linked to menopause, such as hot flashes or discomfort in the vulvar and vaginal regions. Your doctor may adjust the dosage based on your response to the treatment.
- If it’s for preventing postmenopausal osteoporosis, your doctor might start you on Estramon 0.025 mg/day.
- Remember to apply Estramon to a clean, dry area of your lower abdomen or buttocks. Avoid using it on your breasts.
- Cardiovascular Disorders: Estrogen therapy, either alone or combined with progestin, may increase the risk of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and myocardial infarction (MI). Discontinue immediately if suspected.
- Manage any risk factors for arterial vascular disease (e.g., hypertension, diabetes, tobacco use) or venous thromboembolism (e.g., personal or family history of clotting disorders).
- Stroke: Estrogen-alone or combined with progestin may elevate stroke risk, particularly in women aged 50-79. Discontinue promptly if a stroke occurs or is suspected.
- Coronary Heart Disease: Effects on coronary heart disease vary with estrogen therapy. No overall effect on CHD was found with estrogen-alone therapy, but subgroup analysis suggests a potential reduction in CHD events in younger women.
- Venous Thromboembolism: Estrogen therapy, alone or combined with progestin, may elevate the risk of VTE (DVT and PE). Discontinue immediately if a VTE occurs or is suspected.
- Breast Cancer: Findings regarding breast cancer risk vary between estrogen-alone and combined therapy. In some cases, increased risks were reported in users.
- Probable Dementia: Studies show varied findings concerning dementia risks with estrogen therapy. Discuss these risks with your healthcare provider.
- Gallbladder Disease, Visual Abnormalities, Elevated Blood Pressure, and Other Conditions. Estrogen therapy may pose risks related to gallbladder disease, visual abnormalities, increased blood pressure, exacerbation of certain conditions (e.g., asthma, diabetes), and more.
- Laboratory Tests: Serum FSH and estradiol levels might not be useful for managing symptoms. However, these tests may guide dosage adjustments for specific conditions.
- Drug-Laboratory Test Interactions: Estrogen therapy might affect various laboratory tests. Discuss any concerns with your healthcare provider.
If you are considering the import of Estramon to India, please be aware that Estramon can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:
Required Documentation for Import:
- A valid prescription from a qualified medical practitioner.
- Diagnostic reports of the patient.
- Government-issued identification proof for the patient, as recognized by the Government of India.
Order Confirmation Process:
The order for Estramon will be confirmed upon the receipt of the following documents:
- A valid prescription from a qualified doctor.
- An import permit, if applicable.
Availability of Estramon in India:
Estramon is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.
Estramon can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.
IPN (Indian Pharma Network) is dedicated to facilitating the supply of Estramon (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.
Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.
Indian Pharma Network is proficient in sourcing Estramon from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.